Do you want to help drive innovation in Flemingsberg?

Södertörn University is looking for an Innovation Advisor to develop its innovation support and lead Innovation Station – the university’s very own hub for collaboration, idea development, and coworking!

In this role, you will:
– Provide guidance to researchers and faculty on innovation and societal impact
– Build relationships and collaboration agreements with external partners
– Secure funding for development projects and recruit new tenants for Innovation Station
– Organize workshops, events, and networking activities for researchers, students, and organizations

They are looking for someone who is social, driven, and experienced in innovation advising, community-building, or coworking management. This is your chance to help Flemingsberg continue to thrive as a hub for innovation, knowledge, and societal progress.

Do you want to make a difference? Apply today and help shape the future in Flemingsberg!

OptiCell Solutions enters a research collaboration with Karolinska Institutet

With the goal of supporting academia, healthcare, and industry in developing the cell and gene therapies of the future, OptiCell Solutions established its operations in Flemingsberg last year. The company has now entered into a research collaboration with Karolinska Institutet, marking a significant step in the desired direction.

The Park Novum inaugurated!

On November 5, the doors to The Park Novum opened – a new co-working space in Novum Research Park. The festivities came with a Halloween theme, and gathered over 150 participants who celebrated together.

Together for the medicine of the future – Karolinska ATMP Centre and ATMP Centre Uppsala strengthens collaboration in advanced therapies

A letter of intent has been signed between the Karolinska ATMP Center and the ATMP Center Uppsala to deepen collaboration in the field of advanced therapies (ATMP). The initiative was celebrated with a joint kick-off at the end of October, where hopes for new research breakthroughs and benefits for patients were in focus.

Previous 678 Next